Version 3 2024-06-17, 11:45Version 3 2024-06-17, 11:45
Version 2 2024-05-30, 15:11Version 2 2024-05-30, 15:11
Version 1 2015-02-05, 14:49Version 1 2015-02-05, 14:49
journal contribution
posted on 2024-06-17, 11:45authored byCG Davey, AM Chanen, SM Cotton, SE Hetrick, MJ Kerr, Michael BerkMichael Berk, Olivia DeanOlivia Dean, K Yuen, M Phelan, A Ratheesh, MR Schäfer, GP Amminger, AG Parker, D Piskulic, S Harrigan, AJ Mackinnon, BJ Harrison, PD McGorry
The aim of the Youth Depression Alleviation-Combined Treatment (YoDA-C) study is to determine whether antidepressant medication should be started as a first-line treatment for youth depression delivered concurrently with psychotherapy. Doubts about the use of medication have been raised by meta-analyses in which the efficacy and safety of antidepressants in young people have been questioned, and subsequent treatment guidelines for youth depression have provided only qualified support.